Skip to content

Clinical trials

Uterine Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Neoplasms Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20131
20201
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Atavistik Bio, Inc1
Centre Oscar Lambret1
Fore Biotherapeutics1
Gynesonics1
Hospices Civils de Lyon1
Institut Paoli-Calmettes1
Novartis Pharmaceuticals1
ZIWIG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Neoplasms10
Endometrial Neoplasms5
Ovarian Neoplasms5
Uterine Cervical Neoplasms5
Breast Neoplasms2
Leiomyoma2
Neoplasms2
Biliary Tract Neoplasms1
Breast Diseases1
COVID-191

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.